Beta Pharma, Inc. is an emerging specialty pharmaceutical company dedicated to the discovery, development, and commercialization of innovative late stage therapies targeting oncology. Our product pipeline is diverse and undergoing rapid development.
Beta Pharma, Inc. was founded at the Science Park Campus of Yale in 1996 as a contract research organization (CRO) providing custom synthesis services to biotechnology and pharmaceutical companies. Profits from the CRO business helped to fund the fledgling company’s new drug discovery projects, which soon found success in oncology drugs. Since then, Beta Pharma has developed into its own independent pharmaceutical company that focuses on the research, development, and commercialization of innovative new chemical entity (NCE) drugs for oncology. Beta Pharma strives to provide better medicine at an affordable price, to our patients for a better quality of life.
Beta Pharma Unveils its Newly Designed Website!
Check out Beta Pharma's press release about its new web design.
Come Meet Us in ASCO!
The BetaPharma team is excited to announce that will be attending this year's ASCO conference.
Please drop by booth number 24113 to ask about our exciting new drug Icotinib and our other products under development (and grab some popcorn!).
We hope to see you there!
Read more about our latest partnership!